ArticleFrontiers in immunology2026
Serum total bile acids within the normal range are inversely associated with inflammatory indices and Gensini score in patients with premature coronary artery disease.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Both serum bile acids and inflammation have been reported to be associated with coronary artery disease (CAD). However, whether serum total bile acid (TBA) can influence the extent of atherosclerosis in premature CAD (PCAD) patients by modulating immune-inflammation is unknown. Methods: A total of 631 patients with PCAD were enrolled from the First Affiliated Hospital of Xi'an Jiaotong University. Spearman correlation and logistic/linear regression were used to assess the associations between TBA and mediator/outcome variables. The mediating effect of immune-inflammation in the association of TBA with outcomes was further evaluated. Results: TBA was associated with a decreased risk of first myocardial infarction (MI) and a reduced degree of coronary stenosis in PCAD patients. Moreover, the inverse association between TBA and immune-inflammation was observed. Multivariate linear regression showed that for each unit increase in TBA, neutrophil (NEU) decreased by 0.27×10^9/L (β = -0.27, 95% CI: -0.37, -0.16), systemic inflammation response index (SIRI) decreased by 0.12 (β = -0.12, 95% CI: -0.17, -0.06), systemic immune-inflammation index (SII) decreased by 55.25 (β = -55.25, 95% CI: -85.78, -24.72), and C-reactive protein (CRP) decreased by 0.13 mg/L (β = -0.13, 95% CI: -0.25, -0.02). More importantly, the mediation analysis indicated that NEU, CRP, SII, and SIRI statistically explained the association between the TBA and outcomes. Conclusion: TBA is associated with reduced coronary lesion severity, an association that may be linked to chronic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.